Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caduet vs Norvasc for Arterial Protection
NCT01922687Phase 4Unknown
- Sponsor
- Shanghai Institute of Hypertension
- Start
- Apr 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in endothelial dysfunction, sponsored by Shanghai Institute of Hypertension. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
endothelial dysfunction
Beyond the preview
Go deeper on NCT01922687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01922687.